The review is devoted to investigate cardiovascular biomarkers in patients with SARS-CoV-2 associated with a high risk of complications and death. The article provides information on the main cardiovascular biomarkers and pro-inflammatory cytokines in relations to the processes of decompensation in patients with chronic heart failure complicated by ARVI, including the SARS-CoV-2. MeSHwords: heart failure, troponin I, NT-proBNP, cytokines, SARS-CoV-2

Despite all the efforts of medical services, the socio-economic damage caused by chronic heart failure (CHF) is increasing. Approximately 10-40% of patients with CHF also suffer from chronic obstructive pulmonary disease (COPD). The comorbid course of these pathologies aggravates the prognosis of patients. Moderate physical activity is recommended as a non-drug therapy for both pathologies. The aim of the study: was to evaluate the effectiveness of physical rehabilitation in patients with chronic heart failure and chronic obstructive pulmonary disease by determining the levels of NT-proBNP, high-sensitivity C-reactive protein, IL-1β, IL-6, TNF-α. Methods: The study included 240 patients with CHF. After the initial examination, the patients were divided into groups depending on the presence or absence of COPD and the value of LVEF. Subsequently, each group was divided into a subgroup that took part in physical rehabilitation in addition to standard medical therapy and another one consist of patients that received only standard therapy. A year later, the levels of NT-proBNP, high-sensitivity C-reactive protein, IL-1β, IL-6 and TNF-α were re-determined. Results and Conclusion: CHFpEF patients have higher levels of hs-CRP and pro-inflammatory cytokines compared to patients with CHFrEF. The combination of COPD and CHF enhances systemic inflammation and myocardial remodeling processes, determined by the level of NT-proBNP in comparison with the isolated course of CHF. Physical rehabilitation in patients with a comorbid course of COPD and CHF is accompanied by a significant decrease in the levels of pro-inflammatory cytokines, hs-CRP and NT-proBNP. Keywords: chronic heart failure, chronic obstructive pulmonary disease, physical rehabilitation

Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) occupy one of the leading positions among the main causes of morbidity and mortality. Their comorbid course is quite common and adversely affects the prognosis of these patients. To prevent decompensation and reduce hospitalizations in this group of patients, combined methods of management are required. In addition to medical treatment, these methods include physical rehabilitation. The aim of the study: was to evaluate the effectiveness of physical rehabilitation in patients with chronic heart failure and chronic obstructive pulmonary disease using a complex of cardiorespiratory analysis, a monitoring system for patients with chronic heart failure and a 6-minute walk test. Methods: The study included 240 patients with CHF. After the initial examination, the patients were divided into groups depending on the presence or absence of COPD and the value of LVEF. Subsequently, each group was divided into a subgroup that took part in physical rehabilitation in addition to standard medical therapy and another one consist of patients that received only standard therapy. A year later exercise tolerance was re-determined using a complex of cardiorespiratory analysis, a monitoring system for patients with chronic heart failure and a 6-minute walk test (6MWT). Results and Conclusion: Conducting physical rehabilitation in patients with a comorbid course of COPD and CHF is accompanied by a significant improvement in hemodynamic parameters during exercise tests (6MWT). Keywords: chronic heart failure, chronic obstructive pulmonary disease, physical rehabilitation

Nowadays, more than 485 million people in the world suffer from cardiovascular diseases (CVD). According to large epidemiological studies, the group of CVD is the leading cause of death in the world. One of the neurohumoral mechanisms that appears to be a risk factor for CVD is thyroid dysfunction. In this regard, in recent years, more and more attention is paid to the study the influence of subclinical hypothyroidism on the occurrence and development of cardiovascular disorders. MeSH words: cardiovascular diseases, subclinical hypothyroidism

The review is devoted to the diagnostic and prognostic role of cardiotrophin-1 (CT-1) in patients with acute and chronic heart failure (CHF). The article provides information on the main regulatory effect of CT-1 in relation to the processes of cardiovascular remodeling. We considered the prospects of monitoring the plasma concentration of CT-1for the individualization of the assessment of cardiovascular risk in patients with CHF at various stages of the cardiovascular continuum. MeSH words: heart failure, cardiotrophin-1, hypertrophy, fibrosis, cytokines.